# ZYNLONTA
> **BLA761196** · Biologics License Application · Sponsor: ADC Therapeutics SA · Approved 2021-04-23
## Drug
- **FDA Application Number:** BLA761196
- **Application type:** Biologics License Application
- **Brand name:** ZYNLONTA
- **Generic name:** LONCASTUXIMAB TESIRINE
- **Active ingredients:** LONCASTUXIMAB TESIRINE-LPYL
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** ADC Therapeutics SA
- **Manufacturer:** ADC Therapeutics America, Inc.
- **First approval:** 2021-04-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761196)
---
*MORVS · CC0 1.0*